Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer

Nicolai A Schultz; Ib J Christensen; Jens Werner; Nathalia Giese; Benny V Jensen; Ole Larsen; Jon K Bjerregaard; Per Pfeiffer; Dan Calatayud; Svend E Nielsen; Mette Karen Yilmaz; Niels H Holländer; Morten Wøjdemann; Stig E Bojesen; Kaspar Rene Nielsen; Julia S Johansen

doi:10.1371/journal.pone.0067059

Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer

Nicolai A Schultz, Ib J Christensen, Jens Werner, Nathalia Giese, Benny V Jensen, Ole Larsen, Jon K Bjerregaard, Per Pfeiffer, Dan Calatayud, Svend E Nielsen, Mette Karen Yilmaz, Niels H Holländer, Morten Wøjdemann, Stig E Bojesen, Kaspar Rene Nielsen, Julia S Johansen

32 Citationer (Scopus)

Abstract

We tested the hypothesis that high plasma YKL-40 and IL-6 associate with pancreatic cancer and short overall survival.

Originalsprog	Engelsk
Tidsskrift	P L o S One
Vol/bind	8
Udgave nummer	6
Sider (fra-til)	e67059
ISSN	1932-6203
DOI	https://doi.org/10.1371/journal.pone.0067059
Status	Udgivet - 2013

Adgang til dokumentet

10.1371/journal.pone.0067059

Andre filer og links

Link to publication in Scopus

Citationsformater

Schultz, N. A., Christensen, I. J., Werner, J., Giese, N., Jensen, B. V., Larsen, O., Bjerregaard, J. K., Pfeiffer, P., Calatayud, D., Nielsen, S. E., Yilmaz, M. K., Holländer, N. H., Wøjdemann, M., Bojesen, S. E., Nielsen, K. R., & Johansen, J. S. (2013). Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer. P L o S One, 8(6), e67059. https://doi.org/10.1371/journal.pone.0067059

Schultz, NA , Christensen, IJ, Werner, J, Giese, N, Jensen, BV, Larsen, O, Bjerregaard, JK, Pfeiffer, P, Calatayud, D, Nielsen, SE, Yilmaz, MK, Holländer, NH, Wøjdemann, M , Bojesen, SE, Nielsen, KR & Johansen, JS 2013, 'Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer', P L o S One, bind 8, nr. 6, s. e67059. https://doi.org/10.1371/journal.pone.0067059

@article{e7cc6f6f497f49d98e1669bb6e72faf8,

title = "Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer",

abstract = "We tested the hypothesis that high plasma YKL-40 and IL-6 associate with pancreatic cancer and short overall survival.",

author = "Schultz, \{Nicolai A\} and Christensen, \{Ib J\} and Jens Werner and Nathalia Giese and Jensen, \{Benny V\} and Ole Larsen and Bjerregaard, \{Jon K\} and Per Pfeiffer and Dan Calatayud and Nielsen, \{Svend E\} and Yilmaz, \{Mette Karen\} and Holl{\"a}nder, \{Niels H\} and Morten W{\o}jdemann and Bojesen, \{Stig E\} and Nielsen, \{Kaspar Rene\} and Johansen, \{Julia S\}",

year = "2013",

doi = "10.1371/journal.pone.0067059",

language = "English",

volume = "8",

pages = "e67059",

journal = "P L o S One",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "6",

}

TY - JOUR

T1 - Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer

AU - Schultz, Nicolai A

AU - Christensen, Ib J

AU - Werner, Jens

AU - Giese, Nathalia

AU - Jensen, Benny V

AU - Larsen, Ole

AU - Bjerregaard, Jon K

AU - Pfeiffer, Per

AU - Calatayud, Dan

AU - Nielsen, Svend E

AU - Yilmaz, Mette Karen

AU - Holländer, Niels H

AU - Wøjdemann, Morten

AU - Bojesen, Stig E

AU - Nielsen, Kaspar Rene

AU - Johansen, Julia S

PY - 2013

Y1 - 2013

N2 - We tested the hypothesis that high plasma YKL-40 and IL-6 associate with pancreatic cancer and short overall survival.

AB - We tested the hypothesis that high plasma YKL-40 and IL-6 associate with pancreatic cancer and short overall survival.

UR - https://www.scopus.com/pages/publications/84879486919

U2 - 10.1371/journal.pone.0067059

DO - 10.1371/journal.pone.0067059

M3 - Journal article

C2 - 23840582

SN - 1932-6203

VL - 8

SP - e67059

JO - P L o S One

JF - P L o S One

IS - 6

ER -

Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater